Compare FISV & A Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FISV | A |
|---|---|---|
| Founded | 1984 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Laboratory Analytical Instruments |
| Sector | Real Estate | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.7B | 39.8B |
| IPO Year | N/A | 1999 |
| Metric | FISV | A |
|---|---|---|
| Price | $66.39 | $140.69 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 30 | 15 |
| Target Price | $155.76 | ★ $164.13 |
| AVG Volume (30 Days) | ★ 9.3M | 2.0M |
| Earning Date | 02-04-2026 | 02-25-2026 |
| Dividend Yield | N/A | ★ 0.70% |
| EPS Growth | ★ 24.82 | 3.16 |
| EPS | ★ 6.48 | 4.57 |
| Revenue | ★ $21,160,000,000.00 | $6,948,000,000.00 |
| Revenue This Year | N/A | $8.02 |
| Revenue Next Year | $2.45 | $6.28 |
| P/E Ratio | ★ $10.31 | $31.69 |
| Revenue Growth | 5.16 | ★ 6.73 |
| 52 Week Low | $59.56 | $96.43 |
| 52 Week High | $238.59 | $160.27 |
| Indicator | FISV | A |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 44.34 |
| Support Level | N/A | $143.14 |
| Resistance Level | N/A | $150.10 |
| Average True Range (ATR) | 0.00 | 3.46 |
| MACD | 0.00 | 0.30 |
| Stochastic Oscillator | 0.00 | 36.56 |
Fiserv is a leading provider of core processing and complementary services, such as electronic funds transfer, payment processing, and loan processing, for US banks and credit unions, with a focus on small and midsize banks. Following its 2019 merger with First Data, Fiserv also provides payment processing services to merchants. About 10% of the company's revenue is generated internationally.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.